STAAR SURGICAL CO (STAA) Stock Price, Quote, News and Overview
NASDAQ:STAA - Nasdaq - US8523123052 - Common Stock - Currency: USD
STAA Quote, Performance and Key Statistics
STAAR SURGICAL CO
NASDAQ:STAA (1/23/2025, 7:29:38 PM)
After market: 23.6637 -0.29 (-1.2%)23.95
+0.87 (+3.77%)
The current stock price of STAA is 23.95 USD. In the past month the price decreased by -3.51%. In the past year, price decreased by -19.01%.
STAA Latest News, Press Releases and Analysis
Why NASDAQ:STAA Is a Promising High-Growth Stock in the Midst of Consolidation.
Is STAAR SURGICAL CO (NASDAQ:STAA) on the Verge of a Major Breakout as a Strong Growth Stock?
NASDAQ:STAA, a growth stock which is not overvalued.
Despite its growth, STAAR SURGICAL CO (NASDAQ:STAA) remains within the realm of affordability.
Staar Surgical is Now Oversold (STAA)
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
STAAR Surgical to Participate in BTIG Ophthalmology Day
STAA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.51 | 44.53B | ||
| COO | COOPER COS INC/THE | 25.86 | 19.10B | ||
| ALGN | ALIGN TECHNOLOGY INC | 25.2 | 17.53B | ||
| SOLV | SOLVENTUM CORP | 17.69 | 12.72B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.07 | 6.79B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 30.85 | 6.04B | ||
| BLCO | BAUSCH + LOMB CORP | 27.62 | 5.93B | ||
| ICUI | ICU MEDICAL INC | 29.42 | 4.09B | ||
| XRAY | DENTSPLY SIRONA INC | 10.51 | 3.86B | ||
| HAE | HAEMONETICS CORP/MASS | 17.86 | 3.66B | ||
| NEOG | NEOGEN CORP | 29.35 | 2.54B | ||
| UFPT | UFP TECHNOLOGIES INC | 37.45 | 2.01B |
Related screens
About STAA
Company Profile
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The company is headquartered in Monrovia California, California and currently employs 1,056 full-time employees. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The firm is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The firm markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The firm also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
Company Info
STAAR SURGICAL CO
1911 Walker Ave
Monrovia California CALIFORNIA 92630 US
CEO: Caren Mason
Employees: 1057
Company Website: https://www.staar.com/
Investor Relations: https://investors.staar.com
Phone: 16263037902
STAA FAQ
What is the price of STAA?
The current price of STAA is 23.95 USD.
What is the symbol for STAAR SURGICAL CO?
The exchange symbol of STAAR SURGICAL CO is STAA and it is listed on the Nasdaq exchange.
On which exchange is STAA listed?
STAA is listed on the Nasdaq exchange.
Is STAA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for STAA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of STAA.
Does STAA pay dividends?
STAA does not pay a dividend.
What is the Price/Earnings (PE) ratio of STAA?
The PE ratio for STAA is 24.95. This is based on the reported non-GAAP earnings per share of 0.96 and the current share price of 23.95 USD.
What is the Short Interest ratio of STAA?
The outstanding short interest for STAA is 7.22% of its float.
STAA Technical Analysis
STAA Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to STAA. STAA gets an excellent profitability rating and is at the same time showing great financial health properties.
STAA Financial Highlights
Over the last trailing twelve months STAA reported a non-GAAP Earnings per Share(EPS) of 0.96. The EPS decreased by 62.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.38% | ||
| ROA | 4.05% | ||
| ROE | 5.09% | ||
| Debt/Equity | 0 |
STAA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 79% to STAA. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of 22.97% and a revenue growth 6.35% for STAA